The Minoxidil Response Test: Can You Predict If It'll Work Before You Try?

Here's a frustrating fact about minoxidil: roughly 30-40% of men who apply it consistently for six months see little to no improvement. They follow the protocol, use the right product, stay patient through the shedding phase — and nothing happens. For years, the only way to find out if you were a non-responder was to spend six months and find out the hard way.

That's starting to change. A diagnostic test now exists that can predict whether you'll respond to topical minoxidil before you start using it. The science behind it is straightforward, the accuracy is surprisingly high, and it could save non-responders months of wasted effort while pointing them toward alternatives that actually work for their biology.

The Enzyme That Determines Everything

Minoxidil is a prodrug — meaning it doesn't work in its original form. When you apply topical minoxidil to your skin, it needs to be converted into its active form, minoxidil sulfate, by an enzyme called sulfotransferase (SULT1A1). This enzyme lives in the outer root sheath of your hair follicles.

If you have high SULT1A1 activity, the conversion happens efficiently. Minoxidil sulfate opens KATP channels, blood vessels dilate, nutrients flood the follicle, and hair grows. If you have low SULT1A1 activity, the conversion barely happens. You're rubbing a prodrug on your face that never becomes the active drug. It's like putting diesel in a gasoline engine — the right fuel is in the tank, but the engine can't use it.

How the Test Works

The minoxidil response test measures SULT1A1 enzyme activity directly from plucked hair follicles. The process is simple: you pluck a small number of hairs (typically six), send them to a lab, and within 6-8 weeks you get a result that categorizes you as a likely responder or non-responder.

The landmark validation study, published by Goren et al. in the Journal of the American Academy of Dermatology, tested the enzymatic assay against actual clinical outcomes. The results were striking: the test successfully ruled out 95.9% of non-responders to topical minoxidil. In clinical terms, that's 95.9% sensitivity — meaning if the test says you won't respond, it's almost certainly right.

A separate study of 120 patients at a hair loss clinic found that roughly 49% had low levels of sulfotransferase — aligning closely with the known non-response rate to topical minoxidil. The biology and the clinical data match.

The Genetic Side: SULT1A1 Variants

Your SULT1A1 enzyme activity is largely determined by genetics. The SULT1A1 gene has several known variants that correspond to different levels of enzyme activity. If you've done consumer genetic testing (like 23andMe), you may be able to look up your SULT1A1 variants, though interpreting them requires understanding which alleles correspond to high vs low activity.

The key variants break down roughly like this: some allele combinations produce high enzyme activity (likely responder), others produce low activity (likely non-responder), and some are intermediate. This isn't a simple dominant/recessive pattern — it's a spectrum, which is why the enzymatic assay measuring actual enzyme activity is more clinically useful than genetic testing alone.

What to Do If You're a Non-Responder

Being a topical minoxidil non-responder doesn't mean you're out of options. It means the standard topical approach won't work for your specific biology. Several alternatives exist:

Oral Minoxidil

Oral minoxidil bypasses the SULT1A1 bottleneck entirely. When taken as a pill, minoxidil is metabolized in the liver rather than in the follicle — and the liver has a different (and generally more robust) sulfotransferase pathway. Many topical non-responders see results with low-dose oral minoxidil. This requires a prescription, but telehealth providers now make it accessible.

Topical Tretinoin + Minoxidil

A 2025 clinical trial demonstrated that topical tretinoin (retinoic acid) can upregulate sulfotransferase expression in hair follicles. In that study, 43% of predicted non-responders were converted into responders after adding tretinoin. The mechanism is elegant: tretinoin reactivates the enzyme pathway that was genetically underperforming. Some prescription formulas (like those from Happy Head) combine tretinoin with minoxidil in a single application.

Microneedling as an Enhancer

Microneedling has been shown to increase both minoxidil absorption and local gene expression, including sulfotransferase-related pathways. Combining a dermaroller with topical minoxidil may partially compensate for low enzyme activity by increasing the concentration of drug reaching the follicle.

Should You Get Tested?

The practical question: is it worth spending money on a test before starting minoxidil?

The argument for testing: if you're a non-responder, the test saves you 6+ months of daily application and $100-200+ in products. It also points you toward alternatives (oral minoxidil, tretinoin combinations) that actually work for your biology. Time and money saved.

The argument against: the test costs money, takes 6-8 weeks for results, and you could simply start minoxidil and observe. If you see vellus hairs by month 3-4, you're a responder. If you see nothing by month 6, you're likely not. The test gives you the answer faster, but the treatment trial gives it to you cheaper.

Our take: if you have access to the test and can afford it, it's a smart move — especially if your time is more valuable than the test cost. If you'd rather just try and see, commit to a full 6-month trial before concluding you're a non-responder, and have oral minoxidil as your backup plan.

Frequently Asked Questions